action of glp-1 agonist Current Insights, Advantages and Challenges Small Molecule Glucagon-like Peptide 1 Receptor Agonists: A Scoping Review Mechanisms of Action and Therapeutic
Description
Repurposing GLP-1 receptor agonists and novel dual/triple GLP-1, GIP, and glucagon agonists represent promising therapeutic strategies that have shown to be effective in targeting inflammation, tau phosphorylation, synaptic dysfunction, insulin resistance, and oxidative stress

GLP-1 agonists and related medications are prescription drugs and must be prescribed and monitored by a licensed healthcare provider

In addition, GLP-1RAs are valuable in the treatment and prevention of diseases of the nervous and cardiovascular system, endocrine disorders, or metabolic diseases due to their neuroprotective, cardiovascular protective, and metabolic regulatory effects

Prescriptions and a medical evaluation are required for certain products

They are different molecules, different drug classes, and work through completely different mechanisms
